VaccineNot Controlled

Fluzone®/Flucelvax®/Fluarix®

Influenza Vaccine

Multiple (Sanofi, Seqirus, GSK)·FDA 1945 (first flu vaccine)·
0.5mL (standard)0.5mL (high-dose 65+)

Version 2025-04 · Last reviewed April 1, 2025 · Methodology

List Price

$20-30

With Insurance

$0 (ACA mandate)

The Short Version

Plain-language summary

Fluzone (Influenza Vaccine) teaches your immune system to recognize this season's influenza strains before you're exposed. It's reformulated every year because flu viruses constantly mutate.

How it works: The flu vaccine trains the immune system to recognize influenza virus proteins before exposure. When vaccinated, the body creates antibodies and memory B cells that can rapidly mount a defense if the real virus is encountered.

What people most commonly report

Injection site soreness / redness
60-70%
Headache
20%
Runny nose (LAIV)
20% (nasal form)
Fatigue
18%
Muscle aches
15%

Normal immune response; apply ice for 10-20 minutes after injection

Some studies were independent, others were paid for by the company that makes it.

What Else the Evidence Supports

Non-drug options with clinical backing

Baseline immune health may support better outcomes alongside vaccination

Vitamin D (2000-4000 IU/day)Emerging

Reduces respiratory infection risk 40%.

Zinc (15-30mg/day)Emerging

Reduces flu duration by 40%.

Sleep (7-9 hrs)Emerging

<6 hrs = 4x higher infection risk.

Exercise (moderate)Emerging

Reduces respiratory infection risk ~45%.

What This Really Costs

Cost per dose based on current pricing

Per Dose

$33

$0 w/ insurance

without insurance

Full Series (1 doses)

$33

$0 w/ insurance

without insurance

Lifestyle alternative: $0/month in prescriptions. Vitamin D (2000-4000 IU/day) - Reduces respiratory infection risk 40%.

The average American retiree spends $165,000 on healthcare after retirement (Fidelity, 2024). Informed choices today compound over decades.

Related Evidence

Explore related medications reviewed on EvidentMeds

Metabolic & Lifestyle Alternatives

Lifestyle & Immune Health Strategies

Baseline immune health may support better outcomes alongside vaccination

Important context: Evidence quality varies across these approaches. Some are well-studied with randomized controlled trial data; others are based on observational or smaller studies. These interventions are not guaranteed to replace medication for all patients. Discuss with your doctor whether any of these are appropriate for your clinical situation.

Global Prescribing & Pricing

Global flu vaccination rates vary approximately 2× between countries; uptake depends on access, public trust, and healthcare system design

🇺🇸

United States

Free–$40/mo

Rate

48% adult vaccination rate, below the WHO 75% target for elderly

Policy

Universal annual recommendation for 6 months+; voluntary with no systemic recall system

Cover

Free with most insurance; free at pharmacies

🇦🇺

Australia

Free (NIP)/mo

Rate

75% of over-65s, strong population uptake

Policy

National Immunisation Program combines free access, GP recall letters, and pharmacist administration

Cover

Free, National Immunisation Program

🇬🇧

United Kingdom

Free (NHS)/mo

Rate

70% of over-65s, 44% of under-65 at-risk groups

Policy

Systematic GP recall letters sent to all eligible patients; pharmacist and GP administration

Cover

Free, NHS funded

🇫🇷

France

Free for at-risk/mo

Rate

52% of over-65s

Policy

Sécurité Sociale reimbursed; pharmacist-administered vaccination widely available

Cover

Fully reimbursed for at-risk groups

🇯🇵

Japan

~$20–27/mo

Rate

60% of over-65s, school-based programs ended 1994

Policy

Municipal subsidies for elderly; school-based programs discontinued in 1994 after controversy

Cover

Partially subsidized for elderly

Australia achieves 75% elderly flu vaccination with a proactive recall system, GP letters sent directly to every eligible patient. The US achieves 48% despite also providing free access. The lesson: access is not the barrier; proactive outreach is.

Clinical Trials & Funding

Understanding who funds research helps contextualize results. Industry-funded trials are not automatically invalid - they undergo the same FDA review - but declared conflicts and sponsor effects are worth knowing. All linked trials can be verified on ClinicalTrials.gov.

Key Efficacy Results

Effectiveness varies 20-60% by season; average ~40-50% against influenza illness

Referenced Studies

Each study shows its evidence level and Cochrane RoB-2 risk-of-bias rating - tap the bias badge for details.

Evidence & Transparency

Cochrane RoB-2 (Risk of Bias)

Badges reflect an editorial assessment using Cochrane's RoB-2 tool domains: randomization, intervention deviation, missing data, outcome measurement, and selective reporting. These are not certified Cochrane reviews. Learn more ↗

CMS Open Payments

Manufacturer payment disclosures are reported via the CMS Sunshine Act. Disclosure is legally required and does not imply bias or misconduct. Language uses "may," "suggests," or "appears", never definitive clinical claims. CMS Open Payments ↗

Live Clinical Trials

Live from ClinicalTrials.gov · refreshed every 4 hours

Currently enrolling, active, and recently completed studies involving Influenza Vaccine. Data is pulled directly from the U.S. National Library of Medicine.

Recent Research

Live from PubMed · peer-reviewed literature · refreshed every 4 hours

Most recently indexed clinical trials and systematic reviews mentioning Influenza Vaccine in PubMed.

Source Documentation

Structured citations for referenced clinical trials

Each referenced trial is listed with its registry ID, funding source, and bias assessment. Use the copy button to generate a formatted citation.

TrialRegistry IDCite
Fluzone HD vs StandardNCT01427309

Bias ratings use Cochrane RoB-2 methodology. Editorial assessment - not a certified Cochrane review.

Our Methodology

Common Side Effects

While taking this medication, you may experience the following common side effects. We've included tips on how to manage them.

Injection site soreness / redness

60-70%

Normal immune response; apply ice for 10-20 minutes after injection

Headache

20%

Usually mild; OTC pain reliever can help

Fatigue

18%

Normal immune activation; usually 1-2 days

Muscle aches

15%

Acetaminophen or ibuprofen can help; usually resolves in 1-2 days

Low-grade fever

10%

Normal immune response; not a sign of flu infection

Nausea (LAIV intranasal)

8%

Live attenuated nasal spray version; less common with injected form

Runny nose (LAIV)

20% (nasal form)

Specific to the live attenuated nasal spray (FluMist), not injections

Arm soreness / difficulty moving

15%

Normal; move arm frequently after injection to reduce soreness

Chills

7%

Normal immune activation; usually resolves within 24-48 hours

Low appetite

5%

Usually brief; eat lightly and stay hydrated

Serious Adverse Effects

  • Guillain-Barré syndrome (1-2 per million)
  • Severe allergic reaction / anaphylaxis (<1 per million)
  • Vasovagal syncope (fainting after injection)
  • SIRVA, Shoulder injury related to vaccine administration (rare, from improper technique)

Drug Interactions

Moderate Interactions (Caution)

ImmunosuppressantsReduced vaccine effectiveness
WarfarinMonitor INR after injection

When to Contact Your Doctor

This medication requires ongoing medical supervision. The following situations warrant a prompt conversation with your prescribing physician - do not wait for your next scheduled appointment.

Contact soon if you notice

  • Guillain-Barré syndrome (1-2 per million)
  • Severe allergic reaction / anaphylaxis (<1 per million)
  • Vasovagal syncope (fainting after injection)
  • SIRVA, Shoulder injury related to vaccine administration (rare, from improper technique)

Also discuss if you want to

  • Review whether this medication is still appropriate for you
  • Consider dosage adjustments based on response
  • Explore lifestyle or non-drug alternatives
  • Understand stopping or tapering options
  • Plan monitoring labs and follow-up

In the US, call 911 or go to the nearest emergency room for severe symptoms. Poison Control: 1-800-222-1222.

FDA Adverse Event Reports

Patient-filed reports from the FDA FAERS database · refreshed daily

Anecdotal data. Reports are not confirmed causation. Always consult your provider.

Community Reports

User-reported experiences - anonymous & anecdotal

Join the Conversation

Premium subscribers can share their experience and confirm others' reports.

Cancel anytime.

Stopping This Medication Safely

Not Applicable

The flu vaccine is a single annual dose, there is no medication to taper. Immune protection wanes over 6–12 months, which is why annual vaccination is recommended.

Never change or stop a medication without consulting your prescribing physician.

Questions for Your Doctor

$2.99, printable guide for your next appointment

Questions to Ask

  • 1.Should I get the high-dose vaccine (65+)?
  • 2.Is the nasal spray appropriate for my child?
  • 3.Am I in a high-risk group?
  • 4.When is the best time of year to get vaccinated?

Lab Tests to Request

  • Vitamin D level
  • Immunocompromised status check

Medical Disclaimer

The information on this page is compiled from publicly available clinical trial data, FDA prescribing information, and peer-reviewed literature. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medications vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.

Get notified when we update Fluzone®/Flucelvax®/Fluarix®

We'll email you when new evidence, safety updates, or alternatives are added.

No spam. Unsubscribe anytime.

Found this useful?

Help keep EvidentMeds editorially independent and community supported. Every dollar funds transparent medication data.

Support the Mission